Correction to: Procedural and Long-Term Outcomes of Bioresorbable Scaffolds Versus Drug-Eluting Stents in Chronic Total Occlusions: The BONITO Registry (Bioresorbable Scaffolds Versus Drug-Eluting Stents in Chronic Total Occlusions).

Abstract

HomeCirculation: Cardiovascular InterventionsVol. 10, No. 2Correction to: Procedural and Long-Term Outcomes of Bioresorbable Scaffolds Versus Drug-Eluting Stents in Chronic Total Occlusions: The BONITO Registry (Bioresorbable Scaffolds Versus Drug-Eluting Stents in Chronic Total Occlusions) Free AccessCorrectionPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessCorrectionPDF/EPUBCorrection to: Procedural and Long-Term Outcomes of Bioresorbable Scaffolds Versus Drug-Eluting Stents in Chronic Total Occlusions: The BONITO Registry (Bioresorbable Scaffolds Versus Drug-Eluting Stents in Chronic Total Occlusions) Originally published17 Jan 2017https://doi.org/10.1161/HCV.0000000000000021Circulation: Cardiovascular Interventions. 2017;10:e000021This article corrects the followingProcedural and Long-Term Outcomes of Bioresorbable Scaffolds Versus Drug-Eluting Stents in Chronic Total OcclusionsIn the article by Azzalini et al, “Procedural and Long-Term Outcomes of Bioresorbable Scaffolds Versus Drug-Eluting Stents in Chronic Total Occlusions: The BONITO Registry (Bioresorbable Scaffolds Versus Drug-Eluting Stents in Chronic Total Occlusions),” which published online October 7, 2016, and appeared in the October 2016 issue of the journal (Circ Cardiovasc Interv. 2016;9:), a correction is needed.On page 5, Table 2, the table rows read, “Right coronary artery, 110 (20.5%), 29 (19.0%), 81 (21.1%); Left circumflex artery, 229 (42.6%), 53 (34.6%), 176 (45.8%).” It has been changed to read, “Right coronary artery, 229 (42.6%), 53 (34.6%), 176 (45.8%); Left circumflex artery, 110 (20.5%), 29 (19.0%), 81 (21.1%).”On page 5, Table 2, table rows J-CTO score; and Reference vessel diameter, mm, the data has been updated.On page 6, Table 3, table rows Diameter of largest stent/scaffold, mm; Diameter of largest balloon used for postdilatation, mm; Minimal luminal diameter post-PCI, mm; Diameter stenosis post-PCI, %; Contrast volume, mL; Fluoroscopy time (min); and Total procedure time (min), the data has been updated.This correction has been made to the current online version of the article, which is available at http://circinterventions.ahajournals.org/content/9/10/e004284. Previous Back to top Next FiguresReferencesRelatedDetailsRelated articlesProcedural and Long-Term Outcomes of Bioresorbable Scaffolds Versus Drug-Eluting Stents in Chronic Total OcclusionsLorenzo Azzalini, et al. Circulation: Cardiovascular Interventions. 2016;9 February 2017Vol 10, Issue 2 Advertisement Article InformationMetrics © 2017 American Heart Association, Inc.https://doi.org/10.1161/HCV.0000000000000021PMID: 28096169 Originally publishedJanuary 17, 2017 PDF download Advertisement